StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

Diisopropylethylamine → [4-(3-Chloropyridin-2-yl)piperazin-1-yl]-(3-phenyl-1-oxa-2-azaspiro[4.5]dec-2-en-8-yl)methanone

HRID 1013342
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 1013342
[C:1]1([C:7]2[CH2:11][C:10]3([CH2:16][CH2:15][CH:14]([C:17](O)=[O:18])[CH2:13][CH2:12]3)[O:9][N:8]=2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.C(N(C(C)C)C(C)C)C.O.ON1C2C=CC=CC=2N=N1.F[B-](F)(F)F.N1(OC(N(C)C)=[N+](C)C)C2C=CC=CC=2N=N1.[Cl:62][C:63]1[C:64]([N:69]2[CH2:74][CH2:73][NH:72][CH2:71][CH2:70]2)=[N:65][CH:66]=[CH:67][CH:68]=1>C1COCC1>[Cl:62][C:63]1[C:64]([N:69]2[CH2:70][CH2:71][N:72]([C:17]([CH:14]3[CH2:13][CH2:12][C:10]4([O:9][N:8]=[C:7]([C:1]5[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=5)[CH2:11]4)[CH2:16][CH2:15]3)=[O:18])[CH2:73][CH2:74]2)=[N:65][CH:66]=[CH:67][CH:68]=1
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

7

Edukt 5

HCID 81531DiisopropylethylamineHCID 2733207O-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborateHCID 27960291-Hydroxybenzotriazole hydrateHCID 114129441-(3-Chloropyridin-2-yl)piperazineHCID 579514503-Phenyl-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylic acid

Produkt 1

HCID 11976243
[4-(3-Chloropyridin-2-yl)piperazin-1-yl]-(3-phenyl-1-oxa-2-azaspiro[4.5]dec-2-en-8-yl)methanone

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 8028TetrahydrofuranLösungsmittel

Versuchsvorschrift

3-Phenyl-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylic acid (750 mg, 2.9 mmol) was slowly added to a solution of N-ethyldiisopropylamine (1.02 g, 7.1 mmol), 1-hydroxybenzotriazole hydrate (320 mg, 2.4 mmol), O-(benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (758 mg, 2.4 mmol) and 1-(3-chloropyridin-2-yl)piperazine (467 mg, 2.4 mmol) in abs. THF (17 ml). The reaction mixture was stirred overnight and the solvent removed under vacuum. The residue was taken up in EtOAc (100 ml). The precipitate formed was removed by suction-filtration. The organic phase was washed successively with sat. aq. NaCl solution, sat. aq. NaHCO3 solution, sat. aq. ammonium sulphate solution and sat. aq. NaCl solution, dried over magnesium sulphate and the solvent removed under vacuum. The precipitate and the residue were purified by column chromatography (silica gel, hexane/EtOAc 1:1). The desired product [4-(3-chloropyridin-2-yl)piperazin-1-yl]-(3-phenyl-1-oxa-2-azaspiro[4.5]dec-2-en-8-yl)methanone was obtained as a cis isomer (294 mg, 24% of the theoretical amount) and trans isomer (192 mg, 15% of the theoretical amount).

Aufarbeitung

  1. customthe solvent removed under vacuum
  2. customThe precipitate formed
  3. customwas removed by suction-filtration
  4. washThe organic phase was washed successively with sat. aq. NaCl solution, sat. aq. NaHCO3 solution, sat. aq. ammonium sulphate solution and sat. aq. NaCl solution
  5. dry with materialdried over magnesium sulphate
  6. customthe solvent removed under vacuum
  7. customThe precipitate and the residue were purified by column chromatography (silica gel, hexane/EtOAc 1:1)

Quellen und Nachweise

ORD-Eintrag
ord-6d0ee1de9230445fbb0d626e169420f5
Quelldatensatz
uspto-grants-2011_07
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US07981883B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion